While the reduction in price target could be perceived negatively by the market, the maintenance of a Strong Buy rating by Raymond James suggests continued confidence in argenx's fundamentals and future prospects. The impact on the stock price is likely to be neutral in the short term as the decrease in target price is relatively small and is counterbalanced by the reaffirmed strong buy rating.